Rovó, Alicia http://orcid.org/0000-0002-7757-4753
Tichelli, André
Article History
Received: 6 October 2021
Revised: 17 October 2021
Accepted: 20 October 2021
First Online: 9 November 2021
Competing interests
: AR received research funding from Novartis, Alexion, CSL Behring, she has acted as a consultant, taken part in advisory boards, and received honoraria from Novartis, Alexion, Bristol Myers Squibb, AstraZeneca, OrPha Swiss and Swedish Orphan Biovitrum AG. AT has nothing to disclose.
Free to read: This content has been made available to all.